Characterization and Analytical Method Validation for Potential Impurities of a Merchantability Drug Substance Fluoxetine HCl

Documenti analoghi

• Simultaneous Determination of Atezolizumab and Bevacizumab by LC–MS/MS in Rat Plasma and Its Application to a Pharmacokinetic Study
  di: Sudha Divya Madhuri Kallam, et al.
  Pubblicazione: (2025)
• Development and Validation of an RP‐HPLC Method for Organic Impurity Profiling in Baclofen Utilizing Robustness Through a Quality‐by‐Design (QbD) Approach: A Comprehensive Forced Degradation Assessment
  di: Santhosh Kumar Ettaboina, et al.
  Pubblicazione: (2025)
• Multiple Reaction Monitoring LC‐MS/MS Quantification of N‐Nitrosamine Drug Substance Related Impurities of Clonidine in Drug Substance and in Tablet Dosage Form
  di: Bhaskar Vallamkonda, et al.
  Pubblicazione: (2025)
• Quality by Design Based Chromatography Technique Development and Validation for the Medicine Venetoclax (for Chronic Leukemia), in the Context of Impurities Including Degradation Products
  di: Rajeshwari Dandabattina, et al.
  Pubblicazione: (2025)
• Establishing a multi‐method approach for unprecedented detection and quantification of 13 genotoxic impurities (GTIs) in Apixaban drug substance through ultra‐performance liquid chromatography (UPLC)
  di: Sivaprasadu Ganta, et al.
  Pubblicazione: (2024)